HLYKOTCServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31

HealthLynked Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$2.09+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $6.14M
P/E (TTM): –
Dividend yield: –

HealthLynked Corp income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31
Revenue	2.07	3.01	5.72	5.86	6.50	6.13	4.02	2.26	2.10	–
Selling, General & Admin	2.04	3.04	3.62	4.58	4.93	3.06	2.92	–	–	–
General & Administrative	–	–	–	–	–	–	2.92	2.84	1.85	1.54
Operating Expenses	4.18	7.69	9.87	15	12	9.20	7.23	5.23	3.89	3.12
Operating Income	-2.11	-4.68	-4.15	-8.66	-5.33	-3.07	-3.21	-2.97	-1.79	-1.17
Interest Expense	–	–	0.00	0	–	–	0.24	0.19	0.10	0.04
Interest & Investment Income	–	–	0.02	0.01	–	–	–	–	–	–
Income from Equity Investments	-3.28	-6.13	-1.01	-8.82	–	–	–	–	–	–
Other Non-Operating Income	-1.17	-1.45	0.54	0.59	-0.02	-2.68	-2.32	-2.82	-0.79	-0.20
Asset Impairment Charges	–	0.72	0.32	2.75	–	–	–	–	–	–
Gain (Loss) on Investments	–	–	–	0.63	–	-0.28	–	–	–	–
Gain (Loss) on Sale of Assets	0.17	0.00	0	–	–	–	–	–	–	–
Legal Settlements	–	–	–	–	–	-0.71	0.71	–	–	0.04
Pretax Income	–	-6.13	-3.61	-8.07	-11	-5.76	-5.53	-5.79	-2.58	-1.38
Income from Continuing Operations	-3.28	-6.13	-3.61	-8.07	-11	–	–	–	–	–
Income from Discontinued Operations	–	–	-0.07	-0.75	0.29	–	–	–	–	–
Net Income incl. Noncontrolling Interests	–	–	–	–	-10	-5.76	-5.53	-5.79	–	–
Net Income	-3.28	-6.13	-1.01	-8.82	-10	-5.76	-5.53	-5.79	-2.58	-1.38
Net Income to Common	–	–	-1.01	-9.17	-11	-6.20	-5.53	–	–	–
EPS (Basic)(per share)	-1.16	-2.18	0.00	-4.00	-5.00	-4.00	-6.00	-7.00	-4.00	-2.00
EPS (Diluted)(per share)	-1.16	-2.18	0.00	-4.00	-5.00	-4.00	-6.00	-7.00	-4.00	-2.00
Shares Outstanding (Basic, Weighted)(shares)	2.84	2.82	2.63	2.43	2.25	1.43	0.99	0.79	0.70	0.60
Shares Outstanding (Diluted, Weighted)(shares)	2.84	2.82	2.63	2.43	2.25	1.43	0.99	0.79	0.70	0.60
EBITDA	-2.01	-4.39	-3.80	-7.83	-4.50	-2.82	-3.14	-2.95	-1.77	-1.16

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -167.6%
Net margin: -289.3%
Return on equity, FY2025: 73.8%

Financial strength

Current ratio: 0.17
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.1%

Valuation

P/E ratio: –
Price to sales: 4.48
Price to book: –
Dividend yield: –